Jul 4, 2011
Source
Unitat de Neuroimmunologia Clinica, Vall d’Hebron University Hospital, Barcelona, Spain.
Abstract
Background: Health-related quality of life (HRQoL) worsens with multiple sclerosis (MS) relapses and disease progression. Common symptoms including depression and fatigue may contribute to poor HRQoL. Objectives: To report exploratory analyses assessing the impact of fingolimod (FTY720) on HRQoL and depression in a phase II study of relapsing MS. Methods: The Hamburg Quality of Life Questionnaire in MS (HAQUAMS) and Beck Depression Inventory second edition (BDI-II) scores were assessed during a 6-month, placebo-controlled study and optional extension. Results: HAQUAMS total score improved with fingolimod and worsened with placebo. Mean score change from baseline to month 6 was +0.02 with fingolimod 1.25 mg (p<0.05 versus placebo), -0.01 with fingolimod 5.0 mg andþ0.12 with placebo. Categorical data supported a clinically important effect of fingolimod on HRQoL. Fingolimod 1.25 mg was also beneficial over placebo in the fatigue/thinking HAQUAMS sub-domain (p<0.05 versus placebo). Change in mean BDI-II scores from baseline to month 6 and the proportion of patients with BDI-II scores indicative of clinical depression favored fingolimod 1.25 mg over placebo (p<0.05 for both). At month 4, mean BDI-II and HAQUAMS total scores appeared to be maintained in fingolimod-treated patients. Conclusion: Fingolimod 1.25 mg may improve HRQoL and depression at 6 onths compared with placebo in patients with relapsing MS.
- PMID:
- 21727148
- [PubMed – as supplied by publisher]
- information provided by:
Cherie C. Binns RN BS MSCN
===========================================================
Remain CURRENT with Multiple Sclerosis news
and information, when registered
at the MS Views and News website
.
~ Our weekly e-Newsletter is now reaching (87) Countries ~
.
DONATION$ are needed to help us to Educate
.
“MS Views and News” is a 501©(3) organization as
recognized by the Internal Revenue Service
All contributions are tax deductible to the fullest extent allowed by law
.
> Providing You with ‘MS Views and News’, is what we do <
.===========================================================
Disclaimer: ‘MS Views and News’ (MSVN), does not endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews